Related Experiment Video
Updated: Aug 7, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Phenotypic evolution of cells resistant to bromodeoxyuridine
Bromodeoxyuridine (BrdUrd) resistance and thymidine kinase deficiency develop in V79 cells through a gradual, drug-induced transition. BrdUrd acts as both an inducer and selector, leading to complex cellular phenotypes over time.
Area of Science:
- Cell biology
- Genetics
- Biochemistry
Background:
- Bromodeoxyuridine (BrdUrd) is a thymidine analog used to study DNA synthesis and cell proliferation.
- Thymidine kinase (TK) is a crucial enzyme in DNA precursor metabolism, phosphorylating thymidine and BrdUrd.
- Drug resistance mechanisms in mammalian cells are complex and can involve multiple genetic and epigenetic alterations.
Purpose of the Study:
- To investigate the mechanisms of bromodeoxyuridine (BrdUrd) resistance and thymidine kinase (TK) deficiency development in V79 Chinese hamster cells.
- To characterize the phenotypic changes associated with prolonged BrdUrd exposure.
- To explore the role of BrdUrd as both a selective and inductive agent in cellular evolution.
Main Methods:
- Induction of drug resistance using spontaneous and drug-induced mutations in V79 cells.
- Isolation of partially resistant clones via one-step selection in BrdUrd.
- Long-term culture of tolerant populations in BrdUrd-containing medium.
- Measurement of thymidine kinase activity and relative plating efficiency in hypoxanthine/aminopterin/thymidine (HAT) medium.
- Clonal analysis to assess phenotypic modifications.
Main Results:
- Prolonged BrdUrd exposure induced a gradual phenotypic transition, leading to complete BrdUrd resistance and thymidine kinase deficiency.
- Thymidine kinase activity declined logarithmically over 8-10 weeks, correlating with increased growth rate.
- Colony formation in HAT medium decreased exponentially for at least 18 weeks post-TK deficiency.
- Phenotypic modifications were continuous or multistep, occurring in most cells maintained in BrdUrd.
Conclusions:
- Bromodeoxyuridine (BrdUrd) can act as both an inductive and selective agent, driving the evolution of drug-resistant cell populations.
- The development of BrdUrd resistance and thymidine kinase deficiency is a complex, multistep process.
- New models are required to explain the progressive evolution of these cellular phenotypes.
More Related Videos
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
09:345-Ethynyl-2'-Deoxyuridine/Phospho-Histone H3 Dual-Labeling Protocol for Cell Cycle Progression Analysis in Drosophila Neural Stem Cells
Published on: May 4, 2021
Related Concept Videos
Treatment Resistant Cancers
Other Unique Bacteria
Evolution of New Traits in Microbes